Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

A modern control scheme and HD textures clash awkwardly with the boxy old levels of Lara's past, in three of her least ...

AI agents are evolving from merely assisting with tasks to independently performing them. Automations using LLMs are already replacing (rather than just assisting) many business process workflows and ...

The pharmaceutical landscape is undergoing a dramatic transformation. New modalities are reshaping what's possible in drug development, from monoclonal antibodies to RNA therapies, from small ...

A New Risk Landscape. As digital payments surge in India, so does the threat from increasingly sophisticated fraud schemes. The Reserve Bank of India (RBI) recently warned lenders ...

Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the ...

Now comes the interesting thing for business and tax leaders, as this year, the impacts of these massive political transitions are coming home to roost from a policymaking perspective, according to ...

An increase in high-fat, high-fructose foods in people's diets has contributed to a dramatic increase in type 2 diabetes.

Royalty Pharma plc (Nasdaq: RPRX) today announced that it has entered into an agreement with Biogen to provide research and development (R&D) funding of up ...

We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...

Here’s everything you need to know about the latest Google Gemini 2.0 update, including new AI models like Flash, Pro, and ...